Phosphonol
Alternative Names: WR 3689; WR 3689 - phosphothioateLatest Information Update: 15 Oct 2007
At a glance
- Originator University of Chicago
- Developer Hollis-Eden Pharmaceuticals
- Class Radioprotectives; Small molecules
- Mechanism of Action Oxygen radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Radiation injuries
Most Recent Events
- 27 Feb 2004 Preclinical trials in Radiation injuries (Prevention)/Radioprotection in USA (unspecified route)
- 15 Feb 2000 A preclinical study has been added to the pharmacodynamics and adverse events sections
- 29 Jan 1999 Preclinical development for Radiation injuries (Prevention)/Radioprotection in USA (unspecified route)